Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$86,145
+$70,498 QoQ
Shares Held
24,613
+507.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 135 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. VYGR ranks #210 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in VYGR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $86,145 24,613
2026-03-31 $15,647 4,054
2025-12-31 $15,931 4,054
2025-09-30 $18,931 4,054
2025-06-30 $17,959 5,775
2025-03-31 $19,519 5,775
2024-03-31 $400 43
2021-09-30 $142,802 54,298
2021-06-30 $276,250 66,889
2021-03-31 $571,788 121,399
2020-12-31 $587,907 82,225
2020-09-30 $923,433 86,545
2020-06-30 $838,977 66,480
2020-03-31 $670,575 73,287